NAPSA and ovarian clear cell cancer: Then, immunohistochemical analysis of a marker panel allowing the diagnosis of clear cell ovarian carcinoma (WT1/p53/PAX8/HNF1-β/Napsin A) and the evaluation of cell proliferation (Ki-67) was performed (Fig. 2).